Showing results (91-100 of 243) with videos related to

Sort By:
Pageof 25
American Journal of Clinical Oncology|October 1, 1990
Observation after orchiectomy in clinical stage I nonseminomatous germ cell tumor of testis. Mayo Clinic experienceS R Patel, R L Richardson, L Kvols, et al.
Cancer|December 15, 1991
Treatment of primary squamous cell carcinoma of the upper urinary tractO Nativ, H M Reiman, M M Lieber, et al.
European Urology|January 1, 1994
Prostate-specific antigen levels after radical prostatectomy and immediate adjuvant hormonal treatment for stage D1 prostate cancer are predictive of early disease outcomeW S Cheng, E J Bergstralh, M Frydenberg, et al.
The Journal of Urology|July 14, 2000
Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomyN B Itano, M L Blute, B Spotts, et al.
Urology|January 11, 1991
Transurethral resection versus needle biopsy prior to radical prostatectomy for stage C prostate cancer. Influence on progression and survivalO Nativ, E J Bergstralh, E T Boyle, et al.
Cancer|January 15, 1985
Androgen receptor binding activity in human prostate cancerR C Benson, D C Utz, E Holicky, et al.
Mayo Clinic Proceedings|October 1, 1985
Treatment of renal cell carcinoma by in situ partial nephrectomy and extracorporeal operation with autotransplantationH Zincke, D E Engen, K M Henning, et al.
Urology|March 1, 1993
Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor gradeE Kleer, J J Larson-Keller, H Zincke, et al.
Urology|September 1, 1995
Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomyC A Hawkins, E J Bergstralh, M M Lieber, et al.
Oncology (Williston Park, N.Y.)|May 1, 1995
Morbidity of contemporary radical retropubic prostatectomy for localized prostate cancerS E Lerner, M L Blute, M M Lieber, et al.
Pageof 25